I dunno Grinny, at present I would be loathe to put a value on any ultimate T/O price, today’s SP doesn’t have any bearing on it whatsoever.
2591 has been through all trials successfully and how many more indications could be treated; (ultimately ASD or ADHD hopefully).
We now have a pre P3 meeting with the FDA set up, the indications haven’t been mentioned I don’t think.
JP has referred to Reata more than once, personally I don’t think US$7b will cut it so even today I see north of A$50/sh.
Share Price, page-11112
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |